A diverse range of illnesses has been treated with honey since ancient civilizations. There has been growing interest by health care professionals in wound care products based on New Zealand manuka honey and Australian honey of similar Leptospermum spp. In Fiji, local honeys have been used in homes to treat diabetic foot ulcers which have failed to heal by conventional therapeutic methods. This suggests that Fiji honeys may confer antimicrobial activity against the isolates from diabetic foot ulcers and this inference was tested in this study. The antimicrobial activity of 30 natural and two processed honeys was determined using some clinical isolates from diabetic foot ulcers, namely:
Introduction
Although honey is known as a food, there is growing interest in the medicinal properties of honey and its role in the treatment of many different health problems. Honey has many therapeutic properties; however the antibacterial property of honey is one which has evoked great interest among researchers. The antimicrobial property of honey is dependent on several contributing factors. Low water content, high osmolarity (high sugar content) and low pH prevent the growth of many bacteria but do not fully account for the activity of the honeys. The hydrogen peroxide and non-peroxide phytochemical) components of honey contribute to its additional activity (Molan, 1992) . About 70% of honey's natural sugars are made up of glucose and fructose. The enzyme glucose oxidase which is introduced to the honey during nectar collection acts on glucose and produces gluconic acid and hydrogen peroxide upon dilution (White et al., 1963) . In many honeys, heating at elevated temperatures destroys this hydrogen peroxide activity and it is also lost in the presence of catalase (an enzyme that degrades hydrogen peroxide and is present in wound fluid). Honeys that retain activity in the presence of catalase are said to have non-peroxide antibacterial activity, manuka honey from New Zealand being an example of a honey with a high level of such activity (Allen, et al., 1991) .
There is increased development of resistance to every antibiotic introduced in clinical practice (Payne et al., 2007) . Wound infections caused by drug-resistant organisms are common and lead to increased costs, morbidity and mortality. There is an urgent need for the discovery of new antibiotics with novel modes of action.
Honey has been utilized as a wound care product and its usage as a wound healing agent is reported in the treatment of venous leg ulcers (Gethin & Cowman, 2008; Jull et al., 2008) , burns (Subramanian, 1993) , chronic leg ulcers (Oluwatosin et al., 2000) , pressure ulcers (Weheida et al., 1991) and exit sites of central venous catheters (Johnson et al., 2005) . There has been growing interest by health care professionals in wound-care products based on New Zealand Manuka honey and Australian honey of similar Leptospermum spp. (Molan and Betts, 2004) . In Fiji, local honeys have been used in homes to treat diabetic foot ulcers (DFU) which have failed to heal by conventional therapeutic methods. This suggests that Fiji honeys may confer antimicrobial activity against the species infecting DFU and this inference was tested in this study.
Infected foot ulcers are a common cause of morbidity in diabetic patients leading to complications like gangrene and amputations. In Fiji, one in every five people has diabetes and the incidence of foot problems and amputations remains high. Full thickness penetration of the dermis of the foot of diabetic people allows colonization of microbial species and initiates a complex series of reactions which leads to transient wound contamination or clinical infection. The initial microbial burden is low in DFU; however lack of proper care promotes microbial density and diversity. Most of the DFU are polymicrobial in nature (Brodsky et al., 1991; Ramani et al., 1991; Criado et al., 1992; Pathare et al., 1998; Chincholikar & Pal, 2002; Viswanathan et al., 2002) . It has been reported that the prevalence of Staphylococcus aureus amongst Gram-positive bacteria and Pseudomonas aeruginosa amongst Gram-negative bacteria were the most dominant of the flora of DFU, followed by Klebsiella pnuemoniae, Escherichia coli, Proteus mirabilis and Candida albicans, (Bansal et al., 2008) .
There are many published reports on the antimicrobial potency of honey against different microbes and some of these studies have included S. aureus (Cooper et al., 1999; Cooper et al., 2002; Miorin et al., 2003; Al Waili, 2004; French et al., 2005; Basualdo et al., 2007; Mercan et al., 2007) , P. aeruginosa (Cooper et al., 2002; Estrada et al., 2005; Boukraa et al., 2007; Mercan et al., 2007; Mullai & Menon., 2007) , E. coli (Estrada et al., 2005; Fangio et al., 2007; ) , K. pnuemoniae (Al Waili, 2004; Estrada et al., 2005; Mercan et al., 2007) , P. mirabilis (Al Waili, 2004; Estrada et al., 2005) and Candida species (Estrada et al., 2005; Mercan et al., 2007) . 
Materials and methods

Honey Samples
Thirty samples of raw honey were collected by the beekeepers and Two samples from different suppliers of the same floral source were analyzed for comparison purposes. All of the samples were stored at room temperature and in the dark for 2 months until they were tested.
Antimicrobial Activity
The procedure used for evaluating antimicrobial activity was described by Allen and colleagues but without the inclusion of catalase (Allen et al., 1991) . Whereas that method used only S. aureus, in this study six clinical isolates were used. The test organisms: S. aureus, E. coli, P. aeruginosa, P. mirabilis, K. Colony Forming Unit (CFU)/mL), and diluted further to set an inoculum density of 1x10 4 CFU/mL which was used for the test.
Plate preparation: To prepare the assay plates 20 mL of nutrient agar (Merck) for each plate was sterilized and seeded with 100 µL inoculum adjusted to 1x10 4 CFU/mL. 
Calculation of the antibacterial activity of honey
The mean diameter of the clear zone around each phenol standard was measured and squared. From the graph of % phenol against the square of the mean diameter of the clear zone, the activity of each diluted honey sample was calculated. The activity was expressed as the equivalent phenol concentration (% w/v).
Minimum Inhibitory Concentration (MIC)
The MIC was determined as described by Mulu, Belay & Fetene (2004) . This paper tested MIC of honey against all the clinical isolates except for C. albicans. 
Results
Antimicrobial Activity
The antimicrobial activity of the 32 Fijian honeys (natural and processed) against the clinical isolates of DFU is shown in Table 1 , expressed as the concentration of phenol with activity equivalent to that of the undiluted honey (Allen et al., (1991) . The lowest concentration of phenol standard which was able to produce detectable antimicrobial activity in this assay was 4.1% (w/v). The absence of zones of inhibition indicated that the activity could not be detected (ND) for these honeys as it was lower than 4.1% (w/v) phenol equivalent.
Minimum Inhibitory Concentration
The MIC's of the 32 Fijian honeys tested against the clinical isolates from DFU showed marked variation between microorganisms ( Table   2 ). The 2 processed honeys did not inhibit any of the microbes at 9.1% v/v, which is the highest concentration used for this assay.
None of the honeys were able to inhibit C.albicans at 9.1% (v/v).
The MIC values of the 30 natural honeys against the six microbes were between 4.8 and higher than 9.1% (v/v).
Discussion
In this study we have demonstrated that all the 32 Fijian honeys display antimicrobial activity against clinical isolates of DFU. More than half of the honeys demonstrated activity equivalent to that of phenol between 4% and 12% (w/v) ( (Cooper, Molan and Harding, 2002) and against 17 strains of P. aeruginosa isolated from infected burns. (Cooper, Halas and Molan, 2002) . Mean values for the MIC for both types of honey were 7% (v/v) for both studies.
In comparison, the MIC values found in the present study in testing against S. aureus ranged from 7.0->9.1% (v/v) and against P. The faster healing of DFU dressed with honey also may result from the anti-inflammatory and de-sloughing effects of honey. There are numerous reports of these effects being observed clinically in a variety of types of wound as a reduction in odema and pain (Molan, 1999) and improvement in healing outcomes (Gethin & Cowman, 2008) . These beneficial effects of honey, and its lack of adverse effects on wounds (Molan, 1999) , considered along with the findings from the present study, indicate that Fijian honeys can be regarded as a possible treatment option for DFU. The authors are currently recruiting participants for a randomized controlled trial to assess the efficacy of honey against DFU.
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